ANKRD20A17P: A Drug Target / Disease Biomarker (G100421363)

Target Name: ANKRD20A17P

NCBI ID: G100421363

ANKRD20A17P

Other Name(s): Ankyrin repeat domain 20 family member A17, pseudogene | ankyrin repeat domain 20 family member A17, pseudogene

ANKRD20A17P: A Drug Target / Disease Biomarker

ANKRD20A17P is a protein that is expressed in the brain and is involved in the regulation of many cellular processes. It has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease. As a result, ANKRD20A17P has potential as a drug target or biomarker for the treatment of these disorders.

The ANKRD20A17P protein is composed of 20 different amino acids and has a molecular weight of approximately 21 kDa. It is expressed in the brain and is found in various cellular organelles, including the endoplasmic reticulum, endoplasmic reticulum-to-cytoplasmic reticulum (ER-ER) axis, and the nuclear envelope. The protein is involved in the regulation of many cellular processes, including cell signaling, neurotransmitter release, and intracellular signaling pathways.

One of the key functions of ANKRD20A17P is its role in the regulation of neurotransmitter release. This protein has been shown to play a role in the release of various neurotransmitters, including dopamine, serotonin, and endocannabinoids. These neurotransmitters are involved in various cellular processes, including mood regulation, pain perception, and neurotransmission.

In addition to its role in neurotransmission, ANKRD20A17P is also involved in the regulation of cell signaling pathways. This protein has been shown to play a role in the regulation of various signaling pathways, including TGF-β signaling, Wnt signaling, andNotch signaling. These signaling pathways are involved in the regulation of cellular processes, including cell growth, differentiation, and survival.

The ANKRD20A17P protein is also involved in the regulation of intracellular signaling pathways. This protein has been shown to play a role in the regulation of various intracellular signaling pathways, including the PI3K/AKT signaling pathway, the ERK signaling pathway, and the T-cell signaling pathway. These signaling pathways are involved in the regulation of cellular processes, including cell signaling, protein synthesis, and intracellular signaling.

In conclusion, ANKRD20A17P is a protein that is involved in the regulation of many cellular processes in the brain. Its role in the regulation of neurotransmission, cell signaling, and intracellular signaling pathways makes it a potential drug target or biomarker for the treatment of various neurological disorders, including Alzheimer's disease. Further research is needed to fully understand the role of ANKRD20A17P in these disorders and to develop effective treatments.

Protein Name: Ankyrin Repeat Domain 20 Family Member A17, Pseudogene

The "ANKRD20A17P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A17P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets